Patent · US Active

Mutant-selective EGFR inhibitors and uses thereof

US9868723B2 · kind B2 · utility

9Cited by
79References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 29, 2016
Grant dateJan 16, 2018
Priority date—
Expiry dateJul 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.